Literature DB >> 22096013

Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.

Chi Chiu Mok1, Sik Nin Wong, Kwok Man Ma.   

Abstract

OBJECTIVE: To study the BMD of patients with SLE according to the age of disease onset.
METHODS: Consecutive SLE patients were screened for BMD at the hip, lumbar spine and whole body by the dual-energy X-ray absorptiometry (DXA). Comparison was made between patients who had disease onset in childhood (<18 years) and adulthood (≥18 years). Factors associated with low BMD were studied by linear regression.
RESULTS: A total of 395 SLE patients were studied (94% women; 11% childhood-onset disease). Osteoporosis of the lumbar spine and the hip/femoral neck was present in 20 and 10% of the patients, respectively. Childhood-onset SLE patients were less likely to be post-menopausal, but had significantly lower BMI, longer SLE duration and a higher frequency of ever use of high-dose CSs, CYC and AZA. Despite a significantly younger age, the BMD of the hip, femoral neck and lumbar spine was significantly lower in childhood- than adult-onset SLE patients. In linear regression models, childhood-onset disease was an independent factor for lower BMD at the lumbar spine (β = -0.18; P = 0.002), hip (β = -0.20; P = 0.001) and femoral neck (β = -0.16; P = 0.01) after adjustment for age, sex, BMI, smoking, menopause, SLE duration and damage index, duration and current dose of prednisolone treatment and the ever use of high-dose glucocorticoids, other immunosuppressive agents, calcium, vitamin D and the bisphosphonates.
CONCLUSIONS: In adult SLE patients, childhood-onset disease carries a higher risk of osteoporosis, which may possibly be related to a higher cumulative dose of glucocorticoids used for more active disease and failure to achieve a normal peak bone mass during puberty.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096013     DOI: 10.1093/rheumatology/ker306

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Vitamin D status in children with systemic lupus erythematosus and its association with clinical and laboratory parameters.

Authors:  Alhanouf AlSaleem; Ashwaq AlE'ed; Afaf AlSaghier; Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2014-11-04       Impact factor: 2.980

Review 2.  Taxonomy for systemic lupus erythematosus with onset before adulthood.

Authors:  Clovis A Silva; Tadej Avcin; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

3.  Paediatric rheumatic disease: lessons from SLE: children are not little adults.

Authors:  Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 4.  Why targeted therapies are necessary for systemic lupus erythematosus.

Authors:  L Durcan; M Petri
Journal:  Lupus       Date:  2016-09       Impact factor: 2.911

Review 5.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 6.  Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.

Authors:  Claudia Mendoza-Pinto; Adriana Rojas-Villarraga; Nicolás Molano-González; Erick A Jiménez-Herrera; María de la Luz León-Vázquez; Álvaro Montiel-Jarquín; Mario García-Carrasco; Ricard Cervera
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

7.  Coexistence of endocrinopathies in children with rheumatic diseases.

Authors:  Doha Alhomaidah; Afaf Alsagheir; Sulaiman M Al-Mayouf
Journal:  Int J Pediatr Adolesc Med       Date:  2016-05-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.